SCHEMBL629093

SCHEMBL629093

CCCC(=O)Nc1cccc(N)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.68
HDAC4 P56524 1/20 0.68
HDAC1 Q13547 1/20 0.68
HDAC7 Q8WUI4 1/20 0.68
HDAC2 Q92769 1/20 0.68
HDAC10 Q969S8 1/20 0.68
HDAC11 Q96DB2 1/20 0.68
HDAC8 Q9BY41 1/20 0.68
HDAC6 Q9UBN7 1/20 0.68
HDAC9 Q9UKV0 1/20 0.68
HDAC5 Q9UQL6 1/20 0.68
ALDH1A1 P00352 3/20 0.62
DDX3X O00571 1/20 0.61
F2R P25116 8/20 0.60
MTNR1B P49286 1/20 0.57
MAPT P10636 2/20 0.57
NPC1 O15118 2/20 0.57
LMNA P02545 1/20 0.57
RAB9A P51151 1/20 0.57
HPGD P15428 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8392853 0.98 HDAC3 (0.66) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL656830 0.90 HDAC3 (0.73) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL30021444 0.88 HDAC3 (0.78) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL9168407 0.88 HDAC3 (0.78) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL10975643 0.88 F2R (0.73) ALDH1A1F2RMTNR1BMAPTRAB9A
SCHEMBL882782 0.87 F2R (0.70) ALDH1A1F2RTP53
SCHEMBL11418046 0.87 HDAC3 (0.68) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL397243 0.86 POLB (0.67) HDAC3HDAC4HDAC1HDAC7HDAC2
Hydrochloric Acid SCHEMBL8392614 0.85 POLB (0.65) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL13363465 0.85 HDAC1 (0.91) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066749-B2 Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2021-07-20 US claimed
US-20200173034-A1 Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2020-06-04 US claimed
US-10604850-B2 Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2020-03-31 US claimed
US-20180127882-A1 Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2018-05-10 US claimed
WO-2016190865-A1 CORROSION INHIBITION OF HCL TREATMENT FLUIDS WITH ENVIRONMENTALLY COMPATIBLE SOLVENT HALLIBURTON ENERGY SERVICES, INC. (US) 2016-12-01 WO claimed
EP-2419549-A1 CORROSION INHIBITOR COMPOSITIONS COMPRISING THE REACTION PRODUCT FORMED FROM AN ALDEHYDE WITH A THIOL AND/OR AN AMINE FUNCTIONALIZED RING STRUCTURE AND ASSOCIATED METHODS Halliburton Energy Services, Inc. (US) 2012-02-22 EP claimed
US-7994099-B2 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods HALIBURTON ENERGY SERVICES, INC. (US) 2011-08-09 US claimed
WO-2010119235-A1 CORROSION INHIBITOR COMPOSITIONS COMPRISING THE REACTION PRODUCT FORMED FROM AN ALDEHYDE WITH A THIOL AND/OR AN AMINE FUNCTIONALIZED RING STRUCTURE AND ASSOCIATED METHODS HALLIBURTON ENERGY SERVICES, INC. (US) 2010-10-21 WO claimed
US-20100261623-A1 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods HALLIBURTON ENERGY SERVICES, INC. 2010-10-14 US claimed
US-11066749-B2 Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2021-07-20 US disclosed
US-20200173034-A1 Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2020-06-04 US disclosed
US-10604850-B2 Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2020-03-31 US disclosed
US-20180127882-A1 Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2018-05-10 US disclosed
WO-2016190865-A1 CORROSION INHIBITION OF HCL TREATMENT FLUIDS WITH ENVIRONMENTALLY COMPATIBLE SOLVENT HALLIBURTON ENERGY SERVICES, INC. (US) 2016-12-01 WO disclosed
US-4552699-A Process for the preparation of 3-acylaminoanilines HOECHST AKTIENGESELLSCHAFT (DE) 1985-11-12 US disclosed
EP-0159291-A1 Ink composition for the ink-jet printing process CIBA-GEIGY AG (CH) 1985-10-23 EP disclosed
EP-0111844-A1 Process for the preparation of 3-acylaminoanilines HOECHST AKTIENGESELLSCHAFT (DE) 1984-06-27 EP disclosed
US-4163059-A Pesticidally active 4,5-dichloro-3-substituted-phenylimino-1,2-dithiolenes BAYER AKTIENGESELLSCHAFT (DE) 1979-07-31 US disclosed
US-4144231-A Soluble trisazo dyestuffs containing a 2-phenyl-benzimidazolyl, -benzoxazolyl or -benzthiazolyl middle component CASSELLA AKTIENGESELLSCHAFT (DE) 1979-03-13 US disclosed
US-4144230-A Soluble trisazo dyestuffs containing a 2-phenyl-benzimidazolyl, -benzoxazolyl or -benzthiazolyl middle component CASSELLA AKTIENGESELLSCHAFT (DE) 1979-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261623-A1 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods MUC1, CA1, MGMT HDAC3 2938/4885HDAC4 2565/4885HDAC1 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.